The G-protein regulator LGN modulates the activity of the NO receptor soluble guanylate cyclase

Biochemical Journal

Volumn 446, Issue 3, 2012, Pages 445-453

  Chauhan, Swati ^a   Jelen, Filip ^b   Sharina, Iraida ^a   Martin, Emil ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

Activator of G protein signalling 3 (AGS3); cGMP; Leu Gly Asn repeat enriched protein (LGN); Nitric oxide (NO); Soluble guanylate cyclase (sGC)

Indexed keywords

4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; GUANYLATE CYCLASE; GUANYLATE CYCLASE ALPHA1; GUANYLATE CYCLASE BETA1; LGN REPEAT ENRICHED PROTEIN; MESSENGER RNA; NITRIC OXIDE; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL LYSATE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; IC 50; IMMUNOPRECIPITATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SUBUNIT; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CYCLIC GMP; GUANYLATE CYCLASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NITRIC OXIDE; PROTEIN SUBUNITS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84865591861     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20111882     Document Type: Article

References (34)

1. Friebe, A. and Koesling, D. (2009) The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models. Nitric Oxide 21, 149-156
2. Stasch, J. P., Pacher, P. and Evgenov, O. V. (2011) Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease. Circulation 123, 2263-2273
3. Lucas, K. A., Pitari, G. M., Kazerounian, S., Ruiz-Stewart, I., Park, J., Schulz, S., Chepenik, K. P. and Waldman, S. A. (2000) Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 52, 375-414
4. Mergia, E., Russwurm, M., Zoidl, G. and Koesling, D. (2003) Major occurrence of the new α2β1 isoform of NO-sensitive guanylyl cyclase in brain. Cell Signalling 15, 189-195 (Pubitemid 35449122)
5. Derbyshire, E. R., Fernhoff, N. B., Deng, S. and Marletta, M. A. (2009) Nucleotide regulation of soluble guanylate cyclase substrate specificity. Biochemistry 48, 7519-7524
6. Derbyshire, E. R. and Marletta, M. A. (2009) Biochemistry of soluble guanylate cyclase. Handb. Exp. Pharmacol, 17-31
7. Bellamy, T. C., Wood, J., Goodwin, D. A. and Garthwaite, J. (2000) Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc. Natl. Acad. Sci. U.S.A. 97, 2928-2933 (Pubitemid 30159274)
8. Batchelor, A. M., Bartus, K., Reynell, C., Constantinou, S., Halvey, E. J., Held, K. F., Dostmann, W. R., Vernon, J. and Garthwaite, J. (2010) Exquisite sensitivity to subsecond, picomolar nitric oxide transients conferred on cells by guanylyl cyclase-coupled receptors. Proc. Natl. Acad. Sci. U.S.A. 107, 22060-22065
9. Kharitonov, V. G., Russwurm, M., Magde, D., Sharma, V. S. and Koesling, D. (1997) Dissociation of nitric oxide from soluble guanylate cyclase. Biochem. Biophys. Res. Commun. 239, 284-286 (Pubitemid 27480357)
10. Russwurm, M., Mergia, E., Mullershausen, F. and Koesling, D. (2002) Inhibition of deactivation of NO-sensitive guanylyl cyclase accounts for the sensitizing effect of YC-1. J. Biol. Chem. 277, 24883-24888 (Pubitemid 34951789)
11. Bellamy, T. C. and Garthwaite, J. (2001) Sub-second kinetics of the nitric oxide receptor, soluble guanylyl cyclase, in intact cerebellar cells. J. Biol. Chem. 276, 4287-4292
12. Papapetropoulos, A., Zhou, Z., Gerassimou, C., Yetik, G., Venema, R. C., Roussos, C., Sessa, W. C. and Catravas, J. D. (2005) Interaction between the 90-kDa heat shock protein and soluble guanylyl cyclase: physiological significance and mapping of the domains mediating binding. Mol. Pharmacol. 68, 1133-1141 (Pubitemid 41345805)
13. Venema, R. C., Venema, V. J., Ju, H., Harris, M. B., Snead, C., Jilling, T., Dimitropoulou, C., Maragoudakis, M. E. and Catravas, J. D. (2003) Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. Am. J. Physiol. Heart. Circ. Physiol. 285, H669-H678 (Pubitemid 36885899)
14. Balashova, N., Chang, F. J., Lamothe, M., Sun, Q. and Beuve, A. (2005) Characterization of a novel type of endogenous activator of soluble guanylyl cyclase. J. Biol. Chem. 280, 2186-2196
15. Hanafy, K. A., Martin, E. and Murad, F. (2004) CCTη, a novel soluble guanylyl cyclase-interacting protein. J. Biol. Chem. 279, 46946-46953 (Pubitemid 39518348)
16. Russwurm, M., Wittau, N. and Koesling, D. (2001) Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive α2β1 guanylyl cyclase to synaptic membranes. J. Biol. Chem. 276, 44647-44652
17. Meurer, S., Pioch, S., Wagner, K., Muller-Esterl, W. and Gross, S. (2004) AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. J. Biol. Chem. 279, 49346-49354 (Pubitemid 39625822)
18. Cai, C., Hsieh, C. L., Gao, S., Kannan, A., Bhansali, M., Govardhan, K., Dutta, R. and Shemshedini, L. (2011) Soluble guanylyl cyclase α1 and p53 cytoplasmic sequestration and down-regulation in prostate cancer. Mol. Endocrinol. 26, 292-307
19. Sato, M., Blumer, J. B., Simon, V. and Lanier, S. M. (2006) Accessory proteins for G proteins: partners in signaling. Annu. Rev. Pharmacol. Toxicol. 46, 151-187 (Pubitemid 43271187)
20. Martin, E., Czarnecki, K., Jayaraman, V., Murad, F. and Kincaid, J. (2005) Resonance Raman and infrared spectroscopic studies of high-output forms of human soluble guanylyl cyclase. J. Am. Chem. Soc. 127, 4625-4631 (Pubitemid 40489618)
21. Sharina, I. G., Jelen, F., Bogatenkova, E. P., Thomas, A., Martin, E. and Murad, F. (2008) α1 Soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity. J. Biol. Chem. 283, 15104-15113
22. Martin, E., Sharina, I., Kots, A. and Murad, F. (2003) A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation. Proc. Natl. Acad. Sci. U.S.A. 100, 9208-9213 (Pubitemid 37033908)
23. Mujoo, K., Sharin, V. G., Martin, E., Choi, B. K., Sloan, C., Nikonoff, L. E., Kots, A. Y. and Murad, F. (2010) Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation. Nitric Oxide 22, 43-50
24. Koglin, M. and Behrends, S. (2003) A functional domain of the alpha1 subunit of soluble guanylyl cyclase is necessary for activation of the enzyme by nitric oxide and YC-1 but is not involved in heme binding. J. Biol. Chem. 278, 12590-12597 (Pubitemid 36800249)
25. Blumer, J. B., Smrcka, A. V. and Lanier, S. M. (2007) Mechanistic pathways and biological roles for receptor-independent activators of G-protein signaling. Pharmacol. Ther. 113, 488-506 (Pubitemid 46389413)
26. Sharin, V. G., Mujoo, K., Kots, A. Y., Martin, E., Murad, F. and Sharina, I. G. (2011) Nitric oxide receptor soluble guanylyl cyclase undergoes splicing regulation in differentiating human embryonic cells. Stem Cells Dev. 20, 1287-1293
27. Kaushik, R., Yu, F., Chia, W., Yang, X. and Bahri, S. (2003) Subcellular localization of LGN during mitosis: evidence for its cortical localization in mitotic cell culture systems and its requirement for normal cell cycle progression. Mol. Biol. Cell 14, 3144-3155 (Pubitemid 37013116)
28. Vural, A., Oner, S., An, N., Simon, V., Ma, D., Blumer, J. B. and Lanier, S. M. (2010) Distribution of activator of G-protein signaling 3 within the aggresomal pathway: role of specific residues in the tetratricopeptide repeat domain and differential regulation by the AGS3 binding partners Giα and mammalian Inscuteable. Mol. Cell. Biol. 30, 1528-1540
29. Du, Q. and Macara, I. G. (2004) Mammalian Pins is a conformational switch that links NuMA to heterotrimeric G proteins. Cell 119, 503-516 (Pubitemid 39482350)
30. Marty, C., Browning, D. D. and Ye, R. D. (2003) Identification of tetratricopeptide repeat 1 as an adaptor protein that interacts with heterotrimeric G proteins and the small GTPase Ras. Mol. Cell. Biol. 23, 3847-3858 (Pubitemid 36597464)
31. Zhu, J., Wen, W., Zheng, Z., Shang, Y., Wei, Z., Xiao, Z., Pan, Z., Du, Q., Wang, W. and Zhang, M. (2011) LGN/mInsc and LGN/NuMA complex structures suggest distinct functions in asymmetric cell division for the Par3/mInsc/LGN and Gαi /LGN/NuMA pathways. Mol. Cell 43, 418-431
32. Blumer, J. B., Lord, K., Saunders, T. L., Pacchioni, A., Black, C., Lazartigues, E., Varner, K. J., Gettys, T. W. and Lanier, S. M. (2008) Activator of G protein signaling 3 null mice. I. Unexpected alterations in metabolic and cardiovascular function. Endocrinology 149, 3842-3849
33. D'Andrea, L. D. and Regan, L. (2003) TPR proteins: the versatile helix. Trends Biochem. Sci. 28, 655-662 (Pubitemid 37500900)
34. Sans, N., Wang, P. Y., Du, Q., Petralia, R. S., Wang, Y. X., Nakka, S., Blumer, J. B., Macara, I. G. and Wenthold, R. J. (2005) mPins modulates PSD-95 and SAP102 trafficking and influences NMDA receptor surface expression. Nat. Cell Biol. 7, 1179-1190